Literature DB >> 7966543

Pharmacokinetics of florfenicol following intravenous and intramuscular doses to cattle.

R D Lobell1, K J Varma, J C Johnson, R A Sams, D F Gerken, S M Ashcraft.   

Abstract

The disposition of florfenicol after single intravenous and intramuscular doses of 20 mg of florfenicol/kg of body weight (b.w.) to feeder calves was investigated. Serum florfenicol concentrations were determined by a sensitive high performance liquid chromatographic method with a limit of quantitation of 0.025 microgram/ml. The extent of serum protein binding of florfenicol was only 13.2% at a serum florfenicol concentration of 3.0 micrograms/ml. Serum concentration-time data after intravenous administration were best described by a triexponential equation. Total body clearance and steady state volume of distribution were 3.75 ml/min/kg b.w. and 761 ml/kg b.w., respectively. The terminal half-life after intravenous administration was 159 min. The absolute systemic availability after intramuscular administration was 78.5% (range: 59.3-106%) and the harmonic mean of the terminal half-life was 1098 minutes, indicating slow release of the florfenicol from the formulation at the intramuscular injection site.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7966543     DOI: 10.1111/j.1365-2885.1994.tb00241.x

Source DB:  PubMed          Journal:  J Vet Pharmacol Ther        ISSN: 0140-7783            Impact factor:   1.786


  14 in total

1.  Detection of florfenicol resistance genes in Escherichia coli isolated from sick chickens.

Authors:  K Keyes; C Hudson; J J Maurer; S Thayer; D G White; M D Lee
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

2.  Pharmacokinetics and bioavailability of florfenicol following intravenous, intramuscular and oral administrations in rabbits.

Authors:  A M Abd El-Aty; A Goudah; K Abo El-Sooud; H Y El-Zorba; M Shimoda; H H Zhou
Journal:  Vet Res Commun       Date:  2004-08       Impact factor: 2.459

3.  Florfenicol pharmacokinetics in healthy adult alpacas after subcutaneous and intramuscular injection.

Authors:  K Holmes; D Bedenice; M G Papich
Journal:  J Vet Pharmacol Ther       Date:  2011-07-08       Impact factor: 1.786

4.  Pharmacokinetics of florfenicol in cerebrospinal fluid and plasma of calves.

Authors:  B A de Craene; P Deprez; E D'Haese; H J Nelis; W Van den Bossche; P De Leenheer
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

5.  Tissue pharmacokinetics of florfenicol in pigs experimentally infected with Actinobacillus pleuropneumoniae.

Authors:  Jian-Zhong Li; Ki-Fai Fung; Zhang-Liu Chen; Zhen-Ling Zeng; Jie Zhang
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2002 Oct-Dec       Impact factor: 2.441

6.  A comparison of the clinical field efficacy and safety of florfenicol and tilmicosin for the treatment of undifferentiated bovine respiratory disease of cattle in western Canada.

Authors:  B R Hoar; M D Jelinski; C S Ribble; E D Janzen; J C Johnson
Journal:  Can Vet J       Date:  1998-03       Impact factor: 1.008

7.  Pharmacokinetics of florfenicol in healthy pigs and in pigs experimentally infected with Actinobacillus pleuropneumoniae.

Authors:  Jianzhong Liu; Ki-Fai Fung; Zhangliu Chen; Zhenling Zeng; Jie Zhang
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

8.  Comparative plasma pharmacokinetics and tolerance of florfenicol following intramuscular and intravenous administration to camels, sheep and goats.

Authors:  B H Ali; A A Al-Qarawi; M Hashaad
Journal:  Vet Res Commun       Date:  2003-09       Impact factor: 2.459

9.  Synovial fluid pharmacokinetics of tulathromycin, gamithromycin and florfenicol after a single subcutaneous dose in cattle.

Authors:  Meredyth L Jones; Kevin E Washburn; Virginia R Fajt; Somchai Rice; Johann F Coetzee
Journal:  BMC Vet Res       Date:  2015-02-07       Impact factor: 2.741

10.  PK-PD Integration Modeling and Cutoff Value of Florfenicol against Streptococcus suis in Pigs.

Authors:  Zhixin Lei; Qianying Liu; Shuaike Yang; Bing Yang; Haseeb Khaliq; Kun Li; Saeed Ahmed; Abdul Sajid; Bingzhou Zhang; Pin Chen; Yinsheng Qiu; Jiyue Cao; Qigai He
Journal:  Front Pharmacol       Date:  2018-01-17       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.